ArticleInternational journal of molecular sciences2025

Exploring the Impact of TP53 Mutation and Wild-Type Status on the Efficacy of Immunotherapy in Non-Small Cell Lung Cancer.

Alexander Yakobson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.